Raphael Pharmaceutical (RAPH) Cash from Operations (2020 - 2025)
Raphael Pharmaceutical (RAPH) posted Cash from Operations of 46000.0 for Q4 2025, up 370.59% sequentially from 17000.0 in Q3 2025, and up 174.19% YoY from 16776.47 in Q4 2024.
Raphael Pharmaceutical (RAPH) Cash from Operations (2020 - 2025) Analysis & Trends
Raphael Pharmaceutical has reported Cash from Operations for 6 years, with the latest figure at 46000.0 in Q4 2025.
- Quarterly Cash from Operations rose 174.19% year-over-year to 46000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 210000.0 (up 60.53% YoY) and the FY2025 annual result came in at 210000.0, up 60.53% from the prior year.
- Cash from Operations grew to 46000.0 in Q4 2025 per RAPH's latest filing, from 17000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 46000.0 in Q4 2025 and troughed at 704000.0 in Q4 2021.
- A 5-year average of 206150.0 and a median of 190500.0 in 2024 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2023 and 2025: Cash from Operations slumped 386.59% in 2023, then surged 174.19% in 2025.
- Over 5 years, Cash from Operations stood at 704000.0 in 2021, then jumped by 60.65% to 277000.0 in 2022, then soared by 68.23% to 88000.0 in 2023, then rose by 29.55% to 62000.0 in 2024, then jumped by 174.19% to 46000.0 in 2025.
- According to Business Quant data, Cash from Operations over the past three periods registered 46000.0, 17000.0, and 30000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Raphael Pharmaceutical | 28.25 Mn | 28.25 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 46,000.00 |
| Dec 31, 2025 | 46,000.00 |
| Sep 30, 2025 | -17,000.00 |
| Sep 30, 2025 | -17,000.00 |
| Jun 30, 2025 | -30,000.00 |
| Jun 30, 2025 | -30,000.00 |
| Mar 31, 2025 | -209,000.00 |
| Mar 31, 2025 | -209,000.00 |
| Dec 31, 2024 | -62,000.00 |
| Dec 31, 2024 | -62,000.00 |
| Sep 30, 2024 | -80,000.00 |
| Sep 30, 2024 | -80,000.00 |
| Jun 30, 2024 | -218,000.00 |
| Jun 30, 2024 | -218,000.00 |
| Mar 31, 2024 | -172,000.00 |
| Mar 31, 2024 | -172,000.00 |
| Dec 31, 2023 | -88,000.00 |
| Dec 31, 2023 | -88,000.00 |
| Sep 30, 2023 | -501,000.00 |
| Sep 30, 2023 | -501,000.00 |